Back to search
Unresectable Colorectal Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Unresectable Colorectal Cancer trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Unresectable Colorectal Cancer trials you may qualify forThe purpose of this study is to compare how long the participants are disease-free (progression-free survival) and and the length of time until a participant di…
The purpose of this study is to compare how long the participants are disease-free (progression-free survival) when treated with amivantamab and chemotherapy wi…
The purpose of this study is to determine the putative recommended phase 2 dose(s) (RP2Ds) of JNJ-89402638 and to determine the safety of JNJ-89402638 at the RP…
Researchers are looking for a better way to treat people who have solid tumors with HER2-activating mutations. Before a treatment can be approved for people to…
The purpose of this study is to characterize the safety and tolerability of ALTA3263 in adults with advanced solid tumors with KRAS mutations.
The purpose of this study is to evaluate the safety and efficacy of pumitamig in combination with chemotherapy versus bevacizumab in combination with chemothera…
This study aims to assess the clinical benefit of local ablative therapy (LAT) following initial standard first-line systemic treatment including the impact on…
This phase II trial studies how well low dose, reduced frequency nivolumab works in treating patients with cancer that cannot be removed by surgery (unresectabl…